Literature DB >> 9075263

Proline-glutamate interactions in the CNS.

J G Ortiz1, M L Cordero, A Rosado.   

Abstract

1. Crude synaptosomes (P2) and synaptosomal membranes were prepared from normal C57/B110 mouse brains and Wistar rats respectively. 2. [3H]Pro binding to mouse brain synaptic membranes was examined in the presence of competitive NMDA antagonist, MK-801, or HA-966. Conversely, the effects of l-proline on [3H]MK-801 binding were also probed. The effects of l-proline on glutamate-medicated [Ca+2]i levels were tested. 3. The authors could not detect any effect of proline on glutamate-mediated [CA+2]i levels using FURA-2 in synaptosomes or neuroblastoma cells. 4. NMDA competitive antagonists, AP-7, CPP, and CGS 19755 inhibit [3H]Pro binding to mouse brain synaptic membranes. 5. MK-801, a NMDA channel blocker, also inhibits [3H]Pro binding, but 200 mM proline is incapable of inhibiting [3H]MK-801 binding. 6. HA-966, a glycine site partial agonist inhibits [3H]Pro binding. Proline has modest effects on [3H]glycine binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075263     DOI: 10.1016/s0278-5846(96)00164-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  1 in total

1.  Blood-Based Biomarkers of Quinpirole Pharmacology: Cluster-Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and Brain.

Authors:  Willem J van den Brink; Robin Hartman; Dirk-Jan van den Berg; Gunnar Flik; Belén Gonzalez-Amoros; Nanda Koopman; Jeroen Elassais-Schaap; Piet Hein van der Graaf; Thomas Hankemeier; Elizabeth C M de Lange
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.